mRNA Covid vaccine shows promise in boosting cancer survival rates
Researchers have found the mRNA vaccine used against Covid-19 could help improve survival outcomes for cancer patients.
New research suggests the mRNA vaccine technology developed for Covid-19 may have applications beyond pandemic response. The vaccine appears capable of boosting survival rates among cancer patients. The findings point to potential dual benefits from the vaccine platform already in use globally.
Covered byRNZNot covered byStuffNZ Herald1NewsNewstalk ZBOtago Daily TimesNewsroomThe SpinoffBusinessDeskinterest.co.nz
Coverage across the news outlets we track, as at publication.
What outlets are saying
RNZ
Could the Covid-19 vaccine also fight cancer?
New research has round the mRNA vaccine could help boost the survival rate of cancer patients.